A detailed history of Parsons Capital Management Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Parsons Capital Management Inc holds 138,973 shares of CLPT stock, worth $2.16 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
138,973
Previous 105,873 31.26%
Holding current value
$2.16 Million
Previous $570,000 173.16%
% of portfolio
0.1%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$5.3 - $13.18 $175,430 - $436,258
33,100 Added 31.26%
138,973 $1.56 Million
Q1 2024

Apr 22, 2024

SELL
$6.03 - $7.86 $1,809 - $2,358
-300 Reduced 0.28%
105,873 $719,000
Q2 2023

Aug 04, 2023

BUY
$6.54 - $10.58 $61,476 - $99,452
9,400 Added 9.71%
106,173 $768,000
Q1 2023

Apr 17, 2023

SELL
$7.33 - $10.63 $123,261 - $178,754
-16,816 Reduced 14.8%
96,773 $816,000
Q4 2022

Feb 13, 2023

BUY
$7.7 - $11.21 $30,176 - $43,931
3,919 Added 3.57%
113,589 $962,000
Q3 2022

Oct 26, 2022

BUY
$9.82 - $16.49 $216 - $362
22 Added 0.02%
109,670 $1.14 Million
Q1 2022

May 02, 2022

SELL
$7.8 - $11.6 $5,257 - $7,818
-674 Reduced 0.61%
109,648 $1.14 Million
Q4 2021

Feb 07, 2022

BUY
$11.08 - $18.86 $47,200 - $80,343
4,260 Added 4.02%
110,322 $1.24 Million
Q3 2021

Nov 09, 2021

BUY
$16.58 - $22.25 $40,620 - $54,512
2,450 Added 2.36%
106,062 $1.88 Million
Q2 2021

Aug 03, 2021

BUY
$17.23 - $22.77 $51,690 - $68,310
3,000 Added 2.98%
103,612 $1.98 Million
Q1 2021

Apr 28, 2021

SELL
$15.19 - $29.0 $564,642 - $1.08 Million
-37,172 Reduced 26.98%
100,612 $2.13 Million
Q4 2020

Feb 08, 2021

SELL
$5.11 - $15.89 $96,068 - $298,732
-18,800 Reduced 12.01%
137,784 $2.19 Million
Q3 2020

Oct 29, 2020

BUY
$3.19 - $5.89 $15,950 - $29,450
5,000 Added 3.3%
156,584 $855,000
Q1 2020

May 05, 2020

BUY
$3.33 - $6.14 $504,774 - $930,725
151,584 New
151,584 $543,000

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $381M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Parsons Capital Management Inc Portfolio

Follow Parsons Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.